Palter 发表于 2025-3-28 17:05:30

Application of Mycogenic Nanoparticles Against Neurodegenerative Diseases,process, besides the conditions used during the process, such as temperature, pH and substrate concentration. Metal nanoparticles associated with polysaccharides and proteins; depict bioactivity related to treatment of diseases such as neurodegenerative diseases. These nanoparticles are ecologically

adroit 发表于 2025-3-28 19:24:44

,Nanobiotechnology in Parkinson’s Disease,ogical fluids, and novel MRI agents for contrast enhancement in imaging applications. Nanotechnology could also revolutionize the PD therapeutic pipeline, which is currently focused on the relief of motor symptoms. To date, the efficacy of nanotechnology in PD treatment has been supported by a large

CAJ 发表于 2025-3-29 01:38:17

Selenium Nanoparticles as Therapeutic Agents in Neurodegenerative Diseases,context, the selenium nanoparticles play an important role in the application for neurodegenerative diseases. In this chapter, we explain the green synthesis of selenium nanoparticles using eco-friendly methods, their characterization using various analytical techniques and applications in the diagn

FADE 发表于 2025-3-29 05:06:48

http://reply.papertrans.cn/67/6607/660680/660680_44.png

知识 发表于 2025-3-29 10:23:09

http://reply.papertrans.cn/67/6607/660680/660680_45.png

线 发表于 2025-3-29 12:48:57

Nanocarrier-Mediated Drug Delivery Systems for Neurodegenerative Diseases,larity, and surface chemistry of nanoparticles are the determinants of efficacy in transporting across BBB. Nanocarriers can be designed in such a way that it does not alter the effect of the drugs. However, care has to be taken when choosing nanomaterials (NM) as some are nonbiodegradable. They can

Cpap155 发表于 2025-3-29 16:44:35

,Nanolipidic Carriers as Potential Drug Delivery Vehicles in Alzheimer’s Disease,Lipid-based nanosized drug delivery systems seem to be very promising in delivering the entrapped drug to the brain by virtue of their lipidic nature and small size. Lipid-based nanocarriers have the added advantage of very low cytotoxicity and avoidance of P-glycoprotein-mediated efflux activity of

Nomadic 发表于 2025-3-29 23:27:21

http://reply.papertrans.cn/67/6607/660680/660680_48.png

Neuralgia 发表于 2025-3-30 01:54:17

http://reply.papertrans.cn/67/6607/660680/660680_49.png

逢迎春日 发表于 2025-3-30 05:27:40

http://reply.papertrans.cn/67/6607/660680/660680_50.png
页: 1 2 3 4 [5] 6
查看完整版本: Titlebook: Nanobiotechnology in Neurodegenerative Diseases; Mahendra Rai,Alka Yadav Book 2019 Springer Nature Switzerland AG 2019 Alzheimers.parkinso